Literature DB >> 19784927

Pneumococcal biofilms.

Miriam Moscoso1, Ernesto García, Rubens López.   

Abstract

Over 60% of bacterial infections (and up to 80% of chronic infections) are currently considered to involve microbial growth in biofilms. This peculiar form of life poses an array of problems in human clinical practice, from infections associated with the implant of prosthetic devices and dental plaque formation to diseases such as cystic fibrosis, otitis media, and endocarditis. Biofilms are also at the basis of a variety of problems in industry. This report describes the biofilms produced by Streptococcus pneumoniae. This bacterium often colonizes the upper airways in humans as a normal commensal, yet it may spread to other areas of the body, causing otitis media, pneumonia, or invasive diseases such as bacteremia and meningitis. The capacity of S. pneumoniae to form biofilms had not been explored until recently. Several newly developed in vitro systems have allowed to test the capacity of S. pneumoniae to form biofilms, and to analyze the influence of several factors, including DNA and proteins-which play a role in the virulence of this "supergerm" in the formation and development of biofilms. In this brief review, we update the knowledge available on pneumococcal biofilm formation and the unusual features of this structure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19784927

Source DB:  PubMed          Journal:  Int Microbiol        ISSN: 1139-6709            Impact factor:   2.479


  26 in total

1.  Strain-specific regulatory role of eukaryote-like serine/threonine phosphatase in pneumococcal adherence.

Authors:  Shivangi Agarwal; Shivani Agarwal; Preeti Pancholi; Vijay Pancholi
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

Review 2.  Modulation of connexin signaling by bacterial pathogens and their toxins.

Authors:  Liesbeth Ceelen; Freddy Haesebrouck; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Cell Mol Life Sci       Date:  2011-06-09       Impact factor: 9.261

3.  Hyperencapsulated mucoid pneumococcal isolates from patients with cystic fibrosis have increased biofilm density and persistence in vivo.

Authors:  Evida A Dennis; Mamie T Coats; Sarah Griffin; Bing Pang; David E Briles; Marilyn J Crain; W Edward Swords
Journal:  Pathog Dis       Date:  2018-10-01       Impact factor: 3.166

4.  In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases.

Authors:  Mirian Domenech; Ernesto García; Miriam Moscoso
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

5.  The LuxS-dependent quorum-sensing system regulates early biofilm formation by Streptococcus pneumoniae strain D39.

Authors:  Jorge E Vidal; Herbert P Ludewick; Rebekah M Kunkel; Dorothea Zähner; Keith P Klugman
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

Review 6.  Pneumococcal Capsules and Their Types: Past, Present, and Future.

Authors:  K Aaron Geno; Gwendolyn L Gilbert; Joon Young Song; Ian C Skovsted; Keith P Klugman; Christopher Jones; Helle B Konradsen; Moon H Nahm
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

7.  The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms.

Authors:  Carlos J Sanchez; Pooja Shivshankar; Kim Stol; Samuel Trakhtenbroit; Paul M Sullam; Karin Sauer; Peter W M Hermans; Carlos J Orihuela
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

8.  Quorum-sensing systems LuxS/autoinducer 2 and Com regulate Streptococcus pneumoniae biofilms in a bioreactor with living cultures of human respiratory cells.

Authors:  Jorge E Vidal; Kristen E Howery; Herbert P Ludewick; Porfirio Nava; Keith P Klugman
Journal:  Infect Immun       Date:  2013-02-12       Impact factor: 3.441

9.  Antibiotic activity against naive and induced Streptococcus pneumoniae biofilms in an in vitro pharmacodynamic model.

Authors:  Nathalie M Vandevelde; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

10.  EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans.

Authors:  Emma J Robertson; Julie M Wolf; Arturo Casadevall
Journal:  Appl Environ Microbiol       Date:  2012-08-31       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.